Source:http://linkedlifedata.com/resource/pubmed/id/12095994
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
38
|
pubmed:dateCreated |
2002-9-16
|
pubmed:abstractText |
We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/(4-(4-hydroxy-3-isopropyl-5-(4-nitro...,
http://linkedlifedata.com/resource/pubmed/chemical/Acetic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Antithyroid Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroid Hormones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35664-70
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12095994-Acetic Acids,
pubmed-meshheading:12095994-Animals,
pubmed-meshheading:12095994-Antithyroid Agents,
pubmed-meshheading:12095994-Base Sequence,
pubmed-meshheading:12095994-DNA Primers,
pubmed-meshheading:12095994-HeLa Cells,
pubmed-meshheading:12095994-Humans,
pubmed-meshheading:12095994-Metamorphosis, Biological,
pubmed-meshheading:12095994-Receptors, Thyroid Hormone,
pubmed-meshheading:12095994-Thyroid Hormones,
pubmed-meshheading:12095994-Transcription, Genetic,
pubmed-meshheading:12095994-Transfection,
pubmed-meshheading:12095994-Xenopus laevis
|
pubmed:year |
2002
|
pubmed:articleTitle |
A thyroid hormone antagonist that inhibits thyroid hormone action in vivo.
|
pubmed:affiliation |
Section of Neurobiology, Physiology, and Behavior, University of California, Davis, California 95616-8519, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|